Abstract
AbstractHere in this study regarding the over expression of TP, which causes some physical, mental and socio problems like psoriasis, chronic inflammatory disease, tumor angiogenesis and rheumatoid arthritisetc. By this consideration, the inhibition of this enzyme is vital to secure life from serious threats. In connection with this, we have synthesized twenty derivatives of isoquinoline bearing oxadiazole (1–20), characterized through different spectroscopic techniques such as HREI-MS,1H- NMR and13C-NMR and evaluated for thymidine phosphorylase inhibition. All analogues showed outstanding inhibitory potential ranging in between 1.10 ± 0.05 to 54.60 ± 1.50 µM. 7-Deazaxanthine (IC50 = 38.68 ± 1.12 µM) was used as a positive control. Through limited structure activity relationships study, it has been observed that the difference in inhibitory activities of screened analogs are mainly affected by different substitutions on phenyl ring. The effective binding interactions of the most active analogs were confirmed through docking study.
Funder
Higher Education Commission, Pakistan
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Siegel, R. et al. Cancer Statistics. CA: CA-Cancer. J. Clin. 63, 11–30 (2013).
2. Rowinsky, E. K. et al. The pursuit of optimal outcomes in cancer therapy in a new age of rationally designed target-based anticancer agents. Drugs. 60, 1–14 (2000).
3. Jarmula, A. Antifolate inhibitors of thymidylate synthase as anticancer drugs. Mini. Reviews. in Med. chem. 10, 1211–1222 (2010).
4. Bloom, J. D. et al. Evolving strategies for enzyme engineering. Current opinion in structural biology 15, 447–452 (2005).
5. Anna, K. et al. Novel purine nucleoside analogues forhematological malignancies. Recent patents on anti-cancer drug discovery. 3, 123–136 (2008).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring etofenamate hydrazide-hydrazone/copper(II) complexes: Synthesis, anticancer activity, carbonic anhydrase IX inhibition and docking studies;Journal of Molecular Structure;2024-09
2. Novel 1,3,4‐oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation;Drug Development Research;2024-07-02
3. Cholinesterase inhibitors for the treatment of Alzheimer’s disorder: Synthesis, biological analysis and molecular modelling studies of iso-quinoline derivatives;Results in Chemistry;2024-07
4. Pyrrolo[2,1-a]isoquinoline scaffolds for developing anti-cancer agents;RSC Advances;2024
5. 1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent;Current Medicinal Chemistry;2023-07-12